Monday, November 20, 2017

Pharma Reviews: Banning combination drugs: A high-stakes case in point

Except the problem in India is that the pharmaceutical industry has turned to FDCs to escape price control. Back in the day when Drug Price Control Orders established prices of drugs with single ingredients, the pharmaceutical industry decided to combine different drugs into a FDC, thereby creating a ...
Read more: Banning combination drugs: A high-stakes case in point